CDI Bioscience, Inc.

Madison, WI 53704

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $892K
First Award Date 01/01/05
Most Recent Award Date 04/15/07

Key Personnel

Last Name Name Awards Contact
Primiano Thomas Primiano 3

3 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/07 - 03/31/08

DESCRIPTION (provided by applicant): Most commercial therapeutic proteins, such as monoclonal antibodies (Mabs), are produced from traditional hybridoma cultures or genetically engineered Chinese hamster ovary (CHO) cells using large scale : bioreactors. Bioprocessing of therapeutic proteins is exceedingly expensive because of the high costs of ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/06/06 - 03/31/07

DESCRIPTION (provided by applicant): Most commercial therapeutic proteins, such as monoclonal antibodies (Mabs), are produced from traditional hybridoma cultures or genetically engineered Chinese hamster ovary (CHO) cells using large scale : bioreactors. Bioprocessing of therapeutic proteins is exceedingly expensive because of the high costs of ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/05 - 06/30/05

Increased production of protein from senescent cells. Monoclonal antibodies (mAbs) are emerging as robust therapeutic options in the fight against cancer and autoimmune diseases. The estimated market in 2004 for therapeutic mAbs is more than $7 billion from 16 FDA approved biopharmaceutical products. Kilogram quantities of mAbs are produced on i...